Filter By:
November 27, 2018Client News
Gunderson Dettmer client ChargePoint secures $240M Series H

ChargePoint, a client of Gunderson Dettmer, secured a Series H financing of $240 million bringing their total funding raised to more than half a million dollars. This round of funding comes from a diverse group of new investors including American Electric Power, Canada Pension Plan Investment Board, Chevron Technology Ventures, Clearvision, Daimler Trucks & Buses, GIC and Quantum Energy Partners. Existing investors include BMW iVentures, Braemar Energy Ventures, Linse Capital and Siemens.

More
November 13, 2018Client News
Gunderson Client Poynt Raises $100M

Poynt, a connected commerce platform for merchants, raised $100M in Series C funding from Elavon and National Australia Bank (NAB). As stated in the press release, "with this investment, the company will expand into new markets across Asia, Europe and South America, grow its talent base, and invest in product and partner development as it executes its vision to become the operating system (OS) on smart payment terminals worldwide."

More
October 11, 2018Client News
Gunderson Dettmer Advises Histogenics on Public Offering of Common Stock and Warrants

Gunderson Dettmer advised Histogenics Corporation on a follow-on public offering underwritten public offering of 26,155,000 shares of its common stock and warrants to purchase up to 19,616,250 shares of common stock, at a combined purchase price of $0.65 per share of common stock and accompanying warrant, for a total of $17,000,750.00 in aggregate gross proceeds.

More
October 10, 2018Client News
Gunderson Dettmer Advises Aldeyra Therapeutics on Public Offering

Gunderson Dettmer advised Aldeyra Therapeutics, Inc. on a follow-on public offering of 5,250,000 shares at the price to the public of $13.75 per share for a total of $72,187,500 in aggregate gross proceeds. Corporate partner Jay Hachigian, of counsel Keith Scherer, and associates Albert Vanderlaan, Naomi Smith and John Maciejewski led the team advising Aldeyra.

More
October 2, 2018Client Alerts
New California Law Requires Public Companies in California to Increase Board Diversity

With the passage of Senate Bill 826 at the end of September, California has become the first state in the U.S. to require public companies incorporated in California or other public companies with their principal executive offices in California (according their Annual Report on Form 10-K) to have specified numbers of women serving on their Boards of Directors. This alert discusses the new law and its implications for public companies.

More
October 1, 2018Client Alerts
Requirement to Update Non-Compete Agreements for Massachusetts Employees

The Massachusetts Noncompetition Agreement Act goes into effect on October 1, 2018 and will impact employers’ current practices with respect to post-termination non-competes for Massachusetts-based employees. This is relevant to you if you intend to hire Massachusetts-based employees or bind an existing Massachusetts-based employee to a post-term non-compete provision in the future because you will need to make updates to the non-compete provision in your form PIIA.

More
September 27, 2018Client News
Gunderson Dettmer Client Compass Raises $400M at $4.4B Valuation

Real estate platform Compass has raised $400 million in a Series F round of funding to help grow its domestic business as well as open internationally. The deal, led by Softbank’s Vision Fund and Qatar Investment Authority, has the company valued at $4.4 billion; double its valuation from last year.

More
September 14, 2018Firm News
Gunderson Dettmer Wins “Finance & Transactional Impact Deal of the Year” for ARMO BioSciences/Eli Lilly M&A at 2018 LMG Life Sciences Awards

Gunderson Dettmer was recognized for a “Finance & Transactional Impact Deal of the Year” at the 2018 Euromoney LMG Life Sciences Awards. Gunderson Dettmer won the award for its representation of ARMO BioSciences, a late-stage immuno-oncology company, in its $1.6 billion sale to Eli Lilly & Company. Gunderson Dettmer also congratulates Lilly for being shortlisted for the Financial & Corporate In-House Team of the Year award at the same event.

More
September 14, 2018Firm News
Gunderson Dettmer's Silicon Valley Headquarters Heads Downtown

Gunderson Dettmer's Silicon Valley office has relocated to a newly-constructed building in downtown Redwood City, California. The new space reflects evolving work styles, efficient design and new collaboration tools to fit the firm's culture and is designed to appeal to lawyers and clients alike.

More
September 13, 2018Firm News
Best Lawyers names twelve Gunderson Dettmer partners in 2019 edition of the Best Lawyers in the United States

Best Lawyers named twelve Gunderson Dettmer partners to its 2019 peer-reviewed list of the most respected lawyers in their focus areas. Ross L. Burningham, Scott C. Dettmer, Steven R. Franklin, Jay K. Hachigian, James L. Hauser, Sharon J. Hendricks, Andrew Y. Luh, Daniel E. O’Connor, Brooks Stough, Jeffrey C. Thacker, and Thomas F. Villeneuve were all named to Best Lawyers in the United States.

More
July 31, 2018Client News
Gunderson Dettmer Advises SpringCM in $220 Million Acquisition by DocuSign

Gunderson Dettmer acted as legal advisor to SpringCM, a leading cloud-based document generation and contract lifecycle management software company, in its $220 million acquisition by DocuSign. In a definitive agreement announced today, the transaction will further accelerate DocuSign’s broadening of its solution beyond e-signature to the rest of the agreement process—from preparing to signing, acting-on, and managing agreements.  

More
July 24, 2018Client Alerts
Good News Relating to Private Company Stock Plans

As required under the Economic Growth, Regulatory Relief, and Consumer Protection Act enacted in May 2018 (the “2018 Act”), the Securities and Exchange Commission (the “SEC”) issued final rules on July 18th to increase the disclosure threshold from $5 million to $10 million for issuances of securities in reliance on Rule 701 under the Securities Act of 1933.

More